Cours RegeneRx Biopharmaceuticals Inc OTC Bulletin Board
Actions
Produits pharmaceutiques
CA 2021 | 76,76 k 70,19 k | CA 2022 | 76,76 k 70,19 k | Capitalisation | 19,94 M 18,23 M |
---|---|---|---|---|---|
Résultat net 2021 | -1 M -914 k | Résultat net 2022 | -1 M -914 k | VE / CA 2021 | 298 x |
Trésorerie nette 2021 | 66,69 k 60,98 k | Dette nette 2022 | 1,16 M 1,06 M | VE / CA 2022 | 275 x |
PER 2021 |
-13,9
x | PER 2022 |
-11,5
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 55,86% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 86 | 13/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Founder | 86 | 13/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01/01/02 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,30% | 90,02 Md | |
-1,18% | 39,15 Md | |
-15,83% | 31,71 Md | |
+62,86% | 26,47 Md | |
-21,68% | 14,34 Md | |
-8,73% | 12,89 Md | |
-15,05% | 11,18 Md | |
-45,69% | 10,97 Md | |
+4,94% | 8,94 Md |